March 26, 2014 / 6:51 AM / 3 years ago

Belgium's IBA forecasts 2014 revenue growth of 5-10 pct

1 Min Read

BRUSSELS, March 26 (Reuters) - Proton therapy group IBA on Wednesday said it expected revenues to grow by between 5 and 10 percent in 2014, driven by demand for its new products.

The Belgian group, which makes proton therapy centres for hospitals which offer a more targeted way to treat cancer compared with traditional radiotherapy, said the new products included Proteus ONE, a cheaper version of its centres.

They also include Pencil Beam Scanning, which offers millimetre precision when targeting tumours.

IBA said it became less dependent on one-off projects in 2013, as service revenues made up a quarter of its business.

It kept costs low by implementing efficiency programmes and was targeting a 10 percent operating profit margin for 2014 up from 8.6 percent in 2013, it added.

Operating profit before one-off items grew 9.2 percent in 2013 to 18.4 million euros ($25.4 million).

$1 = 0.7258 Euros Reporting by Robert-Jan Bartunek; Editing by Mark Potter

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below